Poorer countries granted access to HIV prevention drug

Lower-income countries will gain access to a “game-changing” HIV prevention drug with a new deal signed between US pharmaceutical giant Gilead and the Global Fund, the health financing group said Wednesday.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup